IgG-Fc片段结合蛋白(FcγBP)重组蛋白
Recombinant Fc Fragment Of IgG Binding Protein (FcgBP)
FOR IN VITRO AND RESEARCH USE ONLY, NOT FOR USE IN CLINICAL DIAGNOSTIC PROCEDURES!
|
Organism species
|
Homo sapiens (Human)
|
|
Product No.
|
KL389Hu01
|
|
Source
|
Prokaryotic expression
|
|
Host
|
E.coli
|
|
Purity
|
> 95%
|
|
UOM
|
50ug
|
|
Predicted Molecular Mass
|
19.4kDa
|
|
Concentration
|
n/a
|
|
Applications
|
SDS-PAGE; WB; ELISA; IP.
|
|
Endotoxin Level
|
<1.0EU per 1µg (determined by the LAL method)
|
|
Residues
|
Cys5176~Ala5344 with N-terminal His-Tag
|
|
Formulation
|
Supplied as lyophilized form in 20mM Tris, 500mM NaCl, pH8.0, containing 1mM EDTA, 1mM DTT, 0.01% sarcosyl, 5% trehalose, and preservative.
|
IgG-Fc片段结合蛋白(FcγBP)重组蛋白SEQUENCES
The sequence of the target protein is listed below.
CTHNG RYLPVNSSLL TSDCSERCSC SSSSGLTCQA AGCPPGRVCE VKAEARNCWA TRGLCVLSVG ANLTTFDGAR GATTSPGVYE LSSRCPGLQN TIPWYRVVAE VQICHGKTEA VGQVHIFFQD GMVTLTPNKG VWVNGLRVDL PAEKLASVSV SRTPDGSLLV RQKA
IgG-Fc片段结合蛋白(FcγBP)重组蛋白USAGE
Reconstitute in sterile ddH2O.
IgG-Fc片段结合蛋白(FcγBP)重组蛋白STORAGE AND STABILITY
Storage: Avoid repeated freeze/thaw cycles. Store at 2-8oC for one month. Aliquot and store at -80oC for 12 months.
Stability Test: The thermal stability is described by the loss rate of the target protein. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37oC for 48h, and no obvious degradation and precipitation were observed. (Referring from China Biological Products Standard, which was calculated by the Arrhenius equation.) The loss of this protein is less than 5% within the expiration date under appropriate storage condition.
IgG-Fc片段结合蛋白(FcγBP)重组蛋白About the MARKER (complimentary)
Effective Size Range: 10kDa to 70kDa.
Protein bands: 10kDa, 14kDa, 18kDa, 22kDa, 26kDa, 33kDa, 44kDa and 70kDa.
Double intensity bands: The 26kDa, 18kDa, 10kDa bands are at double intensity to make location and size approximation of proteins of interest quick and easy.
Ready-to-use: No need to heat, dilute or add reducing agents before use.
KL214Ca01 窖蛋白(CAV1)重组蛋白 Recombinant Caveolin 1 (CAV1) Canis familiaris; Canine (Dog)
KL214Cp01 窖蛋白(CAV1)重组蛋白 Recombinant Caveolin 1 (CAV1) Capra hircus; Caprine (Goat)
KL214Eq01 窖蛋白(CAV1)重组蛋白 Recombinant Caveolin 1 (CAV1) Equus caballus; Equine (Horse)
KL214Ga01 窖蛋白(CAV1)重组蛋白 Recombinant Caveolin 1 (CAV1) Chicken (Gallus)
KL214Hu01 窖蛋白(CAV1)重组蛋白 Recombinant Caveolin 1 (CAV1) Homo sapiens (Human)
KL214Mu01 窖蛋白(CAV1)重组蛋白 Recombinant Caveolin 1 (CAV1) Mus musculus (Mouse)
KL214Po01 窖蛋白(CAV1)重组蛋白 Recombinant Caveolin 1 (CAV1) Sus scrofa; Porcine (Pig)
KL214Ra01 窖蛋白(CAV1)重组蛋白 Recombinant Caveolin 1 (CAV1) Rattus norvegicus (Rat)
KL214Rb01 窖蛋白(CAV1)重组蛋白 Recombinant Caveolin 1 (CAV1) Oryctolagus cuniculus (Rabbit)
KL214Si01 窖蛋白(CAV1)重组蛋白 Recombinant Caveolin 1 (CAV1) Rhesus monkey (Simian)
KL215Bo01 Ⅰ型胶原α2(COL1α2)重组蛋白 Recombinant Collagen Type I Alpha 2 (COL1a2) Bos taurus; Bovine (Cattle)
KL215Ca01 Ⅰ型胶原α2(COL1α2)重组蛋白 Recombinant Collagen Type I Alpha 2 (COL1a2) Canis familiaris; Canine (Dog)
KL215Ga01 Ⅰ型胶原α2(COL1α2)重组蛋白 Recombinant Collagen Type I Alpha 2 (COL1a2) Chicken (Gallus)
KL215Hu01 Ⅰ型胶原α2(COL1α2)重组蛋白 Recombinant Collagen Type I Alpha 2 (COL1a2) Homo sapiens (Human)
KL215Rb01 Ⅰ型胶原α2(COL1α2)重组蛋白 Recombinant Collagen Type I Alpha 2 (COL1a2) Oryctolagus cuniculus (Rabbit)
